In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


This content is currently on FREE ACCESS, enjoy another 15 days of free consultation

 

Do married or co-habiting partners or significant others help or hinder cardiovascular patients in quitting smoking?

Session Moderated poster session - Public health and cardiac rehabilitation

Speaker Smaragda Lampridou

Congress : EuroHeartCare 2019

  • Topic : preventive cardiology
  • Sub-topic : Stress, Psycho-Social and Cultural Aspects of Heart Disease
  • Session type : Moderated Posters
  • FP Number : 20

Authors : S Lampridou (London,GB), C Jennings (London,GB)

15 views

Authors:
S Lampridou1 , C Jennings1 , 1Imperial College London, National Heart and Lungs Institute - London - United Kingdom of Great Britain & Northern Ireland ,

Citation:

Introduction: Patients with existent cardiovascular disease (CVD) and those at high risk of developing CVD continue smoking, despite the recommendation to quit. Comprehensive preventive cardiology interventions, including behavioural strategies and supporting mechanisms between partners, can be effective in smoking cessation. However, there is insufficient evidence concerning the role partners and significant others play in these programmes to influence change towards a smoke-free lifestyle. 

Purpose: To evaluate the influence of the partner (never smoker, ex-smoker or current smoker) with regards to quitting smoking amongst high CVD risk smokers (those who have experienced an event or are at high risk of CVD) during their attendance at a nurse-led, family centred, comprehensive preventive cardiology programmes across Europe, the UK and Ireland. 

Methods: In the EUROACTION trial, EUROACTION plus trial, MyAction Galway and MyAction Westminster programmes, coronary patients and high CVD risk patients were recruited from hospitals and general practice, with their partners, to preventive cardiology programmes. Success rate for quitting smoking amongst high CVD risk smokers was measured at the end of the programme. 

Results: 222 current smokers and their partners attended the initial and the end of the programme assessments. At the initial assessment, no patients and 55% of the partners were meeting the European goal (smoking abstinence), whilst at the end of the programme 64% and 75% sustained abstinence, respectively. The odds of quitting smoking at 16 weeks were significantly higher (5.83) in couples who tried to quit together (p=0.0001). 

Conclusion: During the course of the preventive cardiology programme couples who tried to quit together achieved higher rates of smoking abstinence. Efforts to support smokers in quit attempts should include partners or other family members rather than on individuals alone.

This content is currently on FREE ACCESS, enjoy another 15 days of free consultation

 



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are